We are live on ! Find out more
BLU

BELLUS Health Inc.

Delisted

BLU was delisted on the 28th of June, 2023.

89 hedge funds and large institutions have $711M invested in BELLUS Health Inc. in 2021 Q4 according to their latest regulatory filings, with 42 funds opening new positions, 20 increasing their positions, 19 reducing their positions, and 7 closing their positions.

New
Increased
Maintained
Reduced
Closed

500% more first-time investments, than exits

New positions opened: 42 | Existing positions closed: 7

200% more funds holding in top 10

Funds holding in top 10: 26 (+4)

144% more capital invested

Capital invested by funds: $291M → $711M (+$420M)

62% more funds holding

Funds holding: 5589 (+34)

5% more repeat investments, than reductions

Existing positions increased: 20 | Existing positions reduced: 19

26% less call options, than puts

Call options by funds: $11.6M | Put options by funds: $15.6M

Holders
89
Holders Change
+34
Holders Change %
+61.82%
% of All Funds
1.37%
Holding in Top 10
6
Holding in Top 10 Change
+4
Holding in Top 10 Change %
+200%
% of All Funds
0.09%
New
42
Increased
20
Reduced
19
Closed
7
Calls
$11.6M
Puts
$15.6M
Net Calls
-$3.99M
Net Calls Change
-$8.65M
Name Holding Trade Value Shares
Change
Change in
Stake
RCM
1
RA Capital Management
Massachusetts
$82.4M +$67.9M +10,230,274 New
AG
2
Artal Group
Luxembourg
$68.4M +$21.6M +3,250,000 +62%
PA
3
Perceptive Advisors
New York
$61.5M +$50.7M +7,645,234 New
RI
4
RTW Investments
New York
$48M +$6.64M +1,000,000 +20%
PCOC
5
Power Corp of Canada
Canada
$39.7M +$32.8M +4,937,730 New
Citadel Advisors
6
Citadel Advisors
Florida
$39M +$12M +1,812,356 +60%
Millennium Management
7
Millennium Management
New York
$30.9M -$499K -75,194 -2%
APM
8
Avidity Partners Management
Texas
$30.4M -$7.74M -1,167,000 -24%
LCM
9
Laurion Capital Management
New York
$30.1M +$7.52M +1,132,500 +43%
BC
10
Boxer Capital
California
$25.8M +$1.49M +225,000 +8%
CC
11
Commodore Capital
New York
$25.2M +$20.7M +3,124,613 New
DM
12
Deerfield Management
New York
$19.7M +$16.3M +2,449,000 New
FLAM
13
First Light Asset Management
Minnesota
$18.7M +$15.4M +2,326,528 New
LCM
14
Lynx1 Capital Management
Puerto Rico
$16.1M +$13.3M +2,003,114 New
O
15
OrbiMed
New York
$11.7M -$6.64M -1,000,000 -41%
ACM
16
Altium Capital Management
New York
$11.7M -$2.25M -338,783 -19%
ACM
17
Asymmetry Capital Management
California
$10.3M +$1.38M +208,059 +19%
Janus Henderson Group
18
Janus Henderson Group
United Kingdom
$10.3M -$1.49M -225,246 -15%
TCM
19
Tang Capital Management
California
$9.66M +$7.96M +1,200,000 New
Lord, Abbett & Co
20
Lord, Abbett & Co
New Jersey
$9.55M +$7.87M +1,186,560 New
SCM
21
Silverarc Capital Management
Massachusetts
$8.86M +$4.88M +735,000 +201%
VC
22
Vivo Capital
California
$8.19M +$6.75M +1,017,152 New
Franklin Resources
23
Franklin Resources
California
$8.05M +$6.64M +1,000,029 New
TLP
24
Tri Locum Partners
New York
$7.86M +$19.5K +2,936 +0.3%
Ensign Peak Advisors
25
Ensign Peak Advisors
Utah
$7.66M +$3.72M +560,798 +143%

BLU Hedge Fund Activity: Q4 2021 in Review

89 of the 6,498 institutional investors tracked by Wall St. Rank reported a position in BELLUS Health Inc. (BLU) for Q4 2021, worth a combined $711M — up 144% from $291M a quarter earlier.

Buyers outnumbered sellers: 42 funds opened new BLU positions and 7 closed out — a net gain of 35 holders — while 20 added to existing stakes and 19 trimmed.

The largest buyer was RA Capital Management, opening a new position worth an estimated $67.9M. The largest seller was Acuta Capital Partners, cutting an estimated $9.84M.

  • 89 institutional investors held BELLUS Health Inc. (BLU) as of Q4 2021, up from 55 in Q3 2021.
  • Funds reported $711M of BELLUS Health Inc. stock for Q4 2021, up 144% quarter-over-quarter.
  • 42 funds opened new BELLUS Health Inc. positions in Q4 2021 and 7 closed out, a net change of +35 holders.
  • The largest BELLUS Health Inc. buyer in Q4 2021 was RA Capital Management, an estimated $67.9M added.
  • The largest BELLUS Health Inc. seller in Q4 2021 was Acuta Capital Partners, an estimated $9.84M sold.

Based on aggregated 13F filings for Q4 2021.